
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701. BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701.
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.79 | 39.5 | 2 | 6.83 | 1.72 | 49913958 | 3.09508271 | CS |
4 | -2.0132 | -41.9137241839 | 4.8032 | 6.83 | 1.72 | 14314714 | 3.11657984 | CS |
12 | -5.21 | -65.125 | 8 | 9.256 | 1.72 | 6381967 | 3.72735994 | CS |
26 | -7.13 | -71.875 | 9.92 | 13.3616 | 1.72 | 3152698 | 4.30661989 | CS |
52 | -48.09 | -94.516509434 | 50.88 | 52.8 | 1.72 | 1837750 | 8.10846691 | CS |
156 | -260.25 | -98.9393248175 | 263.04 | 546 | 1.72 | 1458314 | 83.97567486 | CS |
260 | -506.01 | -99.4516509434 | 508.8 | 1198.24 | 1.72 | 1048332 | 176.77213677 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約